Evidence map›Paper›PMID 35628481›Full record

ReviewInternational journal of molecular sciences2022

The Involvement of Alarmins in the Pathogenesis of Sjögren's Syndrome.

Julie Sarrand, Laurie Baglione, Dorian Parisis, Muhammad Soyfoo

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Genome-Wide Identification and Expression Analysis ofAnimals : an open access journal from MDPI · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Aquaporin-5 Dynamic Regulation.International journal of molecular sciences · 2023
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Julie SarrandDepartment of Rheumatology, Hôpital Erasme, Université Libre de Bruxelles, 1070 Brussels, Belgium.ORCID 0000-0002-6833-0044
Laurie BaglioneDepartment of Rheumatology, Hôpital Erasme, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Dorian ParisisDepartment of Rheumatology, Hôpital Erasme, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Muhammad SoyfooDepartment of Rheumatology, Hôpital Erasme, Université Libre de Bruxelles, 1070 Brussels, Belgium.ORCID 0000-0002-9051-1810
Université Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sjögren's syndrome (SS) is a chronic autoimmune disease that affects exocrine glands, primarily the salivary and lachrymal glands. It is characterized by lymphoplasmacytic infiltration of the glandular tissues, ultimately leading to their dysfunction and destruction. Besides classic dry eyes and dry mouth defined as sicca syndrome, patients affected by the disease also typically display symptoms such as fatigue, pain and in more than 50% of cases, systemic manifestations such as arthritis, interstitial lung involvement, neurological involvement and an increased risk of lymphoma. The pathophysiological mechanisms underlying SS still remain elusive. The crucial role of innate immunity has been advocated in recent years regarding the pathogenesis of pSS, especially in the initiation and progression toward autoimmunity. Alarmins are endogenous molecules that belong to the large family of damage associated molecular pattern (DAMP). Alarmins are rapidly released, ensuing cell injury and interacting with pattern recognition receptors (PRR) such as toll-like receptors (TLR) to recruit and activate cells of the innate immune system and to promote adaptive immunity responses. This review highlights the current knowledge of various alarmins and their role in the pathogenesis of pSS.

Indexed as

Lacrimal ApparatusSjogren's SyndromeXerostomiaAlarminsHumansToll-Like ReceptorsAlarminsToll-Like Receptorsalarminsautoimmunitycytokinesdamage associated molecular patterninnate immunitySjögren’s syndrome

Identifiers

PMID35628481
PMCPMC9145074
OpenAlexW4280642067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.